Estrogen replacement may shield hearts of women with premature ovarian failure
NCT ID NCT06866119
First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 26 times
Summary
This study looks at whether 6 months of estrogen replacement therapy can improve heart health in women with primary ovarian insufficiency (POI), a condition that causes early menopause. Researchers will measure blood vessel function and metabolic markers in 45 women aged 30-40 before and after treatment, comparing them to healthy women without POI. The goal is to gather stronger evidence for using estrogen therapy to prevent heart problems in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOTHELIAL FUNCTION (FMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.